First Republic Capital

FSD Pharma Breaks All-time Daily Volume Record and Continues to Make History

TORONTO, Sept. 12, 2018 /CNW/ – FSD Pharma Inc. (“FSD” or the “Company”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9), is pleased to report that on September 11, 2018 the Company traded an aggregate total of exactly 213,761,823 shares. FSD traded 143,260,988 Class B subordinate voting shares on the Canadian Securities Exchange (“CSE”), 1,888,500 on AQC-Lit, 15,369,000 on AQC-Neo, 241,740 on CXC, 5,309,399 on CX2, 6,473,592 on CXD, 22,500 on Lynx, 24,750,500 on Omega and 16,445,604 on MatchNow. This is the largest total quantity of share volume traded by a CSE listed issuer by over 15.7% above the recorded all-time high of 184,718,114 also achieved by FSD on September 10, 2018, as confirmed by the CSE. This record is also  41% over the Company’s previous reporting of achieving an all-time high of 151,183,895 on September 4, 2018.

Continue Reading “FSD Pharma Breaks All-time Daily Volume Record and Continues to Make History”

Khiron Raises $12.9 Million to Expand Colombia Medical Cannabis Operations

TORONTO, Sept. 12, 2018 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV:KHRN, OTCQB:KHRNF), a Canadian integrated medical cannabis company with its core operations in Colombia, is pleased to announce that it has closed today its previously announced best efforts short form prospectus offering of common shares (“Common Shares”), including the exercise in full of the over-allotment option (the “Offering”).

Continue Reading “Khiron Raises $12.9 Million to Expand Colombia Medical Cannabis Operations”

Canntab Therapeutics Launches Capital Markets Communications Strategy

Toronto, Ontario–(Newsfile Corp. – September 11, 2018) – Canntab Therapeutics Limited (CSE: PILL) (the “Company” or “Canntab”) is pleased to announce that, effective today, the Company will be increasing its level of engagement with shareholders and with potential retail and institutional investors. Accordingly, it has retained the services of Mackie Research Capital Corporation (“Mackie Research”) to act as financial advisor to the Company and the services of Hybrid Financial Limited (“Hybrid”) to assist the Company with Investor Relations by effectively communicating the Company’s message to an increasingly broad range of investment advisors across Canada.

Continue Reading “Canntab Therapeutics Launches Capital Markets Communications Strategy”

FSD Pharma Issues 40,000,000 Stock Options to Director Dr. Raza Bokhari Conditional on NASDAQ listing

TORONTO, Sept. 11, 2018 /PRNewswire/ – FSD Pharma Inc. (“FSD Pharma” or the “Company”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) announces that pursuant to its Stock Option Plan, the Board approved the grant of 3,000,000 stock options for class B subordinate voting shares of the Company (the “Options”) on August 14, 2018 to Dr. Raza Bokhari following his appointment as a Director. The Options vest immediately and are exercisable at a price of $0.13 for a period of five years. The Company has also cancelled 15,000,000 stock options that had been previously issued at $0.05.

Continue Reading “FSD Pharma Issues 40,000,000 Stock Options to Director Dr. Raza Bokhari Conditional on NASDAQ listing”

FSD Pharma Congratulates High Tide Ventures for Selection as Supplier to Ontario Cannabis Retail Corporation

TORONTO, Sept. 7, 2018 /CNW/ – FSD Pharma Inc. (“FSD Pharma” or “FSD”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) today congratulated High Tide Ventures Inc. (“High Tide”) for the selection of its wholly-owned subsidiary Famous Brandz Inc. (“Famous Brandz”) as an accessories supplier to the Ontario Cannabis Retail Corporation, operating as the Ontario Cannabis Store (“OCS”). Under the announcement by the OCS on September 5, 2018, Famous Brandz was one of ten accessories suppliers newly-selected to supply accessories to the adult-use market in the Province of Ontario.

Continue Reading “FSD Pharma Congratulates High Tide Ventures for Selection as Supplier to Ontario Cannabis Retail Corporation”

Enforcer Gold accelerates earn-in at Roger gold-copper project

TORONTO, Sept. 4, 2018 /CNW/ – Enforcer Gold Corp (“Enforcer” or the “Company”) (TSX-V: VEIN) (FSE: N071) is pleased to inform its shareholders that the Board of Directors has agreed to accelerate its earn-in schedule on the Roger gold-copper project, for which it recently announced an updated mineral resource estimate. The project is advantageously located 5 km north of the historic mining center Chibougamau, Quebec, has all-season road access and is crossed by a power line that serviced the past-producing Troilus Mine. Enforcer is earning a 50% interest in the project from project operator, SOQUEM.

Continue Reading “Enforcer Gold accelerates earn-in at Roger gold-copper project”